Showing results (41-50 of 93) with videos related to
Sort By:
Pageof 10
Journal of Translational Internal Medicine|February 23, 2026
Methyltransferase like 3 promotes thyroid folliculogenesis via coordinating cell differentiation and polarizationRuoyu Jiang, Qibo Zhu, Zhenlei Zhang, et al.Molecular Pharmaceutics|November 28, 2023
Human Serum Albumin-Platinum(II) Agent Nanoparticles Inhibit Tumor Growth Through Multimodal Action Against the Tumor MicroenvironmentShihang Xu, Weicong Luo, Minghui Zhu, et al.Journal of Medicinal Chemistry|September 13, 2023
Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and MetastasisWenjuan Li, Shanhe Li, Gang Xu, et al.Molecular Pharmaceutics|February 26, 2020
Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor MicroenvironmentZhenlei Zhang, Juzheng Zhang, Ming Jiang, et al.Journal of Inorganic Biochemistry|April 11, 2017
Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albuminYao Zhang, Zhenlei Zhang, Yi Gou, et al.Journal of Medicinal Chemistry|March 24, 2026
Developing a Multitargeted Anticancer Bi-Copper(II)-Centered Thiocarbohydrazone Agent Based on Lys-199 and His-242 Residues in the IIA Subdomain of Human Serum AlbuminShanhe Li, Xiaojun Wang, Ming Jiang, et al.Journal of Medicinal Chemistry|May 23, 2023
Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of CancerXueyu Man, Tongfu Yang, Wenjuan Li, et al.Journal of Medicinal Chemistry|November 13, 2020
Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and ApoptosisJuzheng Zhang, Zhenlei Zhang, Ming Jiang, et al.Journal of Medicinal Chemistry|March 29, 2024
Developing a Copper(II) Isopropyl 2-Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin-Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor MicroenvironmentXueyu Man, Shanhe Li, Gang Xu, et al.Journal of Medicinal Chemistry|September 19, 2024
Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung CancerWenjuan Li, Shanhe Li, Minghui Zhu, et al.Pageof 10